1887
Volume 2022, Issue 4
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Background: Qatar has a unique demographic composition, involving hundreds of thousands of male blue-collar workers living in places where physical distancing measures are difficult to implement. This study aimed to describe the rapid development and operations of a temporary isolation facility, which was composed of tents, for asymptomatic COVID-19 positive migrant workers.

Design: The government established several temporary isolation facilities to house this important group of the community. This was achieved through daily meetings over a short period, thanks to the collaboration of government and private partners, in parallel to the facility being built and required resources procured.

Results: A 3,726-patient capacity isolation facility composed of large tents was constructed in 1 month and was kept operational from April 16 to June 20, 2020. Over that period, it received a total of 18,900 patients. It took 10 days from the decision to set up the first part of the isolation facility to admitting its first occupants.

Conclusions: The COVID-19 pandemic necessitated the implementation of unprecedented global public health and physical distancing measures to contain the spread of the virus among the population. Rapidly opening a temporary COVID-19 isolation facility bought the healthcare sector time to set up more permanent solutions to contain the spread of the virus.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2022.55
2022-11-15
2022-12-07
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2022/4/qmj.2022.55.html?itemId=/content/journals/10.5339/qmj.2022.55&mimeType=html&fmt=ahah

References

  1. Zhang L, Liu Y. Potential interventions for novel coronavirus in China: A systematic review. J Med Virol. 2020;92:479–90. doi: 10.1002/jmv.25707, PMID 32052466.
    [Google Scholar]
  2. Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91:157–60. doi:10.23750/abm.v91i1.9397, PMID 32191675.
    [Google Scholar]
  3. Lawal Y. Africa’s low COVID-19 mortality rate: A paradox? Int J Infect Dis. 2021;102:118–22. doi:10.1016/j.ijid.2020.10.038, PMID 33075535.
    [Google Scholar]
  4. Siddiqi HK, Libby P, Ridker PM. COVID-19 - A vascular disease. Trends Cardiovasc Med. 2021; 31:(1):1–5. doi:10.1016/j.tcm.2020.10.005, PMID 33068723.
    [Google Scholar]
  5. Khanna RC, Cicinelli MV, Gilbert SS, Honavar SG, Murthy GSV. COVID-19 pandemic: lessons learned and future directions. Indian J Ophthalmol. 2020;68:703–10. doi:10.4103/ijo.IJO_843_20, PMID 32317432.
    [Google Scholar]
  6. Alwahaibi N, Al Maskari M, Al Dhahli B, Al Issaei H, Al-Jaaidi ShadiAl Bahlani S. One-year review of COVID-19 in the Arab world. Qatar Med J. 2021;2021:66. doi:10.5339/qmj.2021.66, PMID 34888202.
    [Google Scholar]
  7. Tawengi AM, Johnston S, Albayat SS, Bansal D, Ahmed S, Sallam MA, et al.. Pre-symptomatic and asymptomatic transmission of COVID-19: implications for control measures in Qatar. Qatar Med J. 2021;2021. doi:10.5339/qmj.2021.59.
    [Google Scholar]
  8. Chen S, Zhang Z, Yang J, Wang J, Zhai X, Bärnighausen T, et al.. Fangcang shelter hospitals: a novel concept for responding to public health emergencies. Lancet. 2020;395:1305–14. doi:10.1016/S0140-6736(20)30744-3, PMID 32247320.
    [Google Scholar]
  9. Alattar R, Ibrahim TBH, Shaar SH, Abdalla S, Shukri K, Daghfal JN, et al.. Tocilizumab for the treatment of severe coronavirus disease 2019. J Med Virol. 2020;92:2042–9. doi:10.1002/jmv.25964, PMID 32369191.
    [Google Scholar]
  10. Kasilingam D, Sathiya Prabhakaran SP, Rajendran DK, Rajagopal V, Santhosh Kumar T, Soundararaj A. Exploring the growth of COVID‐19 cases using exponential modelling across 42 countries and predicting signs of early containment using machine learning. Transbound Emerg Dis. 2021;68:1001–18. doi:10.1111/tbed.13764, PMID 32749759.
    [Google Scholar]
  11. Al Kuwari HM, Abdul Rahim HFA, Abu-Raddad LJ, Abou-Samra AB, Al Kanaani Z, Al Khal A, et al.. Epidemiological investigation of the first 5685 cases of SARS-CoV-2 infection in Qatar, 28 February 2018 April 2020. BMJ Open. 2020;10:e040428. doi:10.1136/bmjopen-2020-040428, PMID 33033033.
    [Google Scholar]
  12. World Health Organization. Coronavirus disease. Vol. 72. 2020; WHO 2019 (COVID-19): situation report.
  13. Alajmi J, Jeremijenko AM, Abraham JC, Alishaq M, Concepcion EG, Butt AA, et al.. COVID-19 infection among healthcare workers in a national healthcare system: the Qatar experience. Int J Infect Dis. 2020;100:386–9. doi:10.1016/j.ijid.2020.09.027, PMID 32949777.
    [Google Scholar]
  14. Alinier G, Morris B, Abu J, Al Shaikh L, Owen R. Implementation of a drive-through testing clinic in Qatar for residents having recently returned from a country with a COVID-19 travel warning. Qatar Med J. 2020; 2020:(3):42. doi:10.5339/qmj.2020.42, PMID 33628713.
    [Google Scholar]
  15. Qatar Ministr of Public Health. Coronavirus disease 2019 (COVID-19) business and leisure – Phase 3 [Internet]. Qatar MOPH. 2020.
    [Google Scholar]
  16. Mehmood A, Maung Z, Consunji RJ, El-Menyar A, Peralta R, Al-Thani H, et al.. Work related injuries in Qatar: a framework for prevention and control. J Occup Med Toxicol. 2018;13:29. doi:10.1186/s12995-018-0211-z, PMID 30202423.
    [Google Scholar]
  17. Favas C, Checchi F, Waldman RJ. Guidance for the prevention of COVID-19 infections among high-risk individuals in urban settings [Internet]. London School of Hygiene and Tropical Medicine: health in Humanitarian Crises Centre, 2020.
    [Google Scholar]
  18. Wilder-Smith A, Freedman DO. Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak. J Travel Med. 2020; 27:(2):1–4. doi:10.1093/jtm/taaa020, PMID 32052841.
    [Google Scholar]
  19. Collings DG, McMackin J, Nyberg AJ, Wright PM. Strategic human resource management and COVID‐19: emerging challenges and research opportunities. J Manag Stud. 2021;58:1378–82. doi:10.1111/joms.12695.
    [Google Scholar]
  20. Gangaram P, Alinier G, Menacho AM. Crisis resource management in emergency medical settings in Qatar. Int Paramed Pract. 2017; 7:(2):18–23. doi:10.12968/ippr.2017.7.2.18.
    [Google Scholar]
  21. Worldometers. COVID-19. Qatar: Coronavirus Pandemic [Intenet]; 2021.
  22. Shillitoe S, Al-Anzi N, Gharib R, Gueddes A, Ragbheer S, David Morris B. Improving wellbeing for COVID-19 patients at Umm Salal Isolation and Recovery Facility through expressive drawing (Art Therapy): A Service/Quality Improvement Initiative. J Emerg Med Trauma Acute Care. 2022; 2022:(1). doi:10.5339/jemtac.2022.qhc.23.
    [Google Scholar]
  23. Banerjee D, Rai M. Social isolation in Covid-19: the impact of loneliness. SAGE Publications Sage UK. London, England; 2020. p. 525–7.
    [Google Scholar]
  24. Zainal Deen N, Al-Sharafi A, Abdalla M, Mushtaha M, Mohamed A, Saleem S, et al.. Prevalence of depression and anxiety among male patients with COVID-19 in Lebsayyer Field Hospital, Qatar. Qatar Med J. 2021; 2021:(3):68. doi:10.5339/qmj.2021.68, PMID 34926191.
    [Google Scholar]
  25. Chen X, Zhang Y, Zhu B, Zeng J, Hong W, He X, et al.. Associations of clinical characteristics and antiviral drugs with viral RNA clearance in patients with COVID-19 in Guangzhou, China. 4/1/2020:2020: Available at SSRN. doi:10.2139/ssrn.3566234.
    [Google Scholar]
  26. Jiang X, Niu Y, Li X, Li L, Cai W, Chen Y, et al.. Is a 14-day quarantine period optimal for effectively controlling coronavirus disease 2019 (COVID-19)? medRxiv. 2020: 2020.03.15.20036533.
    [Google Scholar]
  27. Foppiani A, Bertoli S, Battezzati A, Zuccotti G. Data to guide the application of the new WHO criteria for releasing COVID-19 patients from isolation. Pharmacol Res. 2020;160:105063. doi:10.1016/j.phrs.2020.105063, PMID 32663611.
    [Google Scholar]
  28. Chow‐In Ko P, Chen WJ, Huei‐Ming Ma M, Chiang WC, Su CP, Huang CH, et al.. Emergency medical services utilization during an outbreak of severe acute respiratory syndrome (SARS) and the incidence of SARS‐associated coronavirus infection among emergency medical technicians. Acad Emerg Med. 2004;11:903–11.
    [Google Scholar]
  29. Lane DJ, Wunsch H, Saskin R, Cheskes S, Lin S, Morrison LJ, et al.. Assessing severity of illness in patients transported to hospital by paramedics: external validation of 3 prognostic scores. Prehosp Emerg Care. 2020;24:273–81. doi:10.1080/10903127.2019. 1632998, PMID 31210571.
    [Google Scholar]
  30. Labib A, Alinier G. Transport and retrieval on extracorporeal membrane oxygenation (ECMO): setup and activities of an immersive transport and retrieval on ECMO workshop. J Cardiothorac Vasc Anesth. 2021;35:1603–10. doi:10.1053/j.jvca.2020.11.069, PMID 33431274.
    [Google Scholar]
  31. Al Jazairi AFH, Alinier G. Emergency health care access. In: Agrawal A, Kosgi S, editors. Healthcare access. London: IntechOpen; 2022. p. 171–88
    [Google Scholar]
  32. Verbeek PR, McClelland IW, Silverman AC, Burgess RJ. Loss of paramedic availability in an urban emergency medical services system during a severe acute respiratory syndrome outbreak. Acad Emerg Med. 2004;11:973–8. doi:10.1197/j.aem.2004.03.021, PMID 15347550.
    [Google Scholar]
  33. Higginson R, Jones B, Kerr T, Ridley A-M. Paramedic use of PPE and testing during the COVID-19 pandemic. J Paramed Pract. 2020;12:221–5. doi:10.12968/jpar.2020.12.6.221.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2022.55
Loading
/content/journals/10.5339/qmj.2022.55
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): COVID-19, IsolationFacilitiesInfection controlTemporary and Tent site
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error